Back to Results
First PageMeta Content
Vaccines / Acetamides / Neuraminidase inhibitors / Pandemics / Influenza vaccine / Flu season / Peramivir / FluMist / Oseltamivir / Medicine / Influenza / Health


oregon_health_authority_final_black and white all black
Add to Reading List

Document Date: 2015-01-14 11:58:38

Open Document

File Size: 428,10 KB

Share Result on Facebook

City

Portland / /

Company

The Oregon State Public Health Laboratory / BioCryst Pharmaceuticals / Fiore AE / /

Country

United States / /

/

Event

FDA Phase / /

Facility

cir†The Oregon State Public Health Laboratory / /

/

IndustryTerm

healthcare workers / latter / /

MedicalCondition

HIV infection / suspected influenza / hypertension / H3N2-predominant flu / flu / strain / SITUATION UPDATE Widespread* influenza / complications influenza / particularly severe influenza / OREGON HEALTHTH AUTHORITY ORECON DEPATMENT OF HUMAN SERVICES INFLUENZA / Influenza A / influ1 enza-like illness / patient’s disease / progressive illness / oseltamivir confirmed influenza / diabetes mellitus / firmed influenza / sickle cell disease / B. All influenza A / cough / metabolic disorders / illness / influenza / /

MedicalTreatment

Immunization / immunosuppression / vaccination / chemoprophylaxis / /

Organization

FDA / Oregon State Public Health Lab / CD Summary Oregon Health Authority/Public Health Division / DIVISION OREGON PUBLIC HEALTH DIVISION / /

Person

Charles Brown / /

/

Product

Tamiflu / Relenza / Tamiflu® / /

ProvinceOrState

Alaska / Maryland / Oregon / /

Technology

http / pdf / /

URL

http /

SocialTag